Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $30.2B |
| FY2017, ended Dec 31, 2017 | $34.8B |
| FY2018, ended Dec 31, 2018 | $29.1B |
| FY2019, ended Dec 31, 2019 | $39.2B |
| FY2020, ended Dec 31, 2020 | $47.8B |
| FY2021, ended Dec 31, 2021 | $68.9B |
| FY2022, ended Dec 31, 2022 | $62.5B |
| FY2023, ended Dec 31, 2023 | $96.2B |
| FY2024, ended Dec 31, 2024 | $130B |
| FY2025, ended Dec 31, 2025 | $124B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $166B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $19.7B |
| FY2017, ended Dec 31, 2017 | $20.4B |
| FY2018, ended Dec 31, 2018 | $21.6B |
| FY2019, ended Dec 31, 2019 | $21.4B |
| FY2020, ended Dec 31, 2020 | $17.9B |
| FY2021, ended Dec 31, 2021 | $19.6B |
| FY2022, ended Dec 31, 2022 | $20.8B |
| FY2023, ended Dec 31, 2023 | $23.2B |
| FY2024, ended Dec 31, 2024 | $24.9B |
| FY2025, ended Dec 31, 2025 | $27.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $30.0B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.92B | $2.07B |
| FY2017, ended Dec 31, 2017 | $2.98B | $2.15B |
| FY2018, ended Dec 31, 2018 | $2.15B | $2.09B |
| FY2019, ended Dec 31, 2019 | $2.21B | $2.86B |
| FY2020, ended Dec 31, 2020 | $1.41B | $2.56B |
| FY2021, ended Dec 31, 2021 | $2.14B | $1.59B |
| FY2022, ended Dec 31, 2022 | $2.46B | $1.94B |
| FY2023, ended Dec 31, 2023 | $3.22B | $2.87B |
| FY2024, ended Dec 31, 2024 | $3.79B | $3.52B |
| FY2025, ended Dec 31, 2025 | $4.09B | $3.55B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $3.83B | $3.93B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $543M |
| FY2017, ended Dec 31, 2017 | $561M |
| FY2018, ended Dec 31, 2018 | $283M |
| FY2019, ended Dec 31, 2019 | $370M |
| FY2020, ended Dec 31, 2020 | $438M |
| FY2021, ended Dec 31, 2021 | $297M |
| FY2022, ended Dec 31, 2022 | $294M |
| FY2023, ended Dec 31, 2023 | $488M |
| FY2024, ended Dec 31, 2024 | $555M |
| FY2025, ended Dec 31, 2025 | $622M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $483M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $8.28B |
| FY2017, ended Dec 31, 2017 | $7.75B |
| FY2018, ended Dec 31, 2018 | $7.52B |
| FY2019, ended Dec 31, 2019 | $8.32B |
| FY2020, ended Dec 31, 2020 | $8.06B |
| FY2021, ended Dec 31, 2021 | $8.58B |
| FY2022, ended Dec 31, 2022 | $8.65B |
| FY2023, ended Dec 31, 2023 | $9.27B |
| FY2024, ended Dec 31, 2024 | $9.15B |
| FY2025, ended Dec 31, 2025 | $9.89B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $20.6B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 13.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 450M |
| FY2017, ended Dec 31, 2017 | 440M |
| FY2018, ended Dec 31, 2018 | 424M |
| FY2019, ended Dec 31, 2019 | 413M |
| FY2020, ended Dec 31, 2020 | 398M |
| FY2021, ended Dec 31, 2021 | 399M |
| FY2022, ended Dec 31, 2022 | 398M |
| FY2023, ended Dec 31, 2023 | 400M |
| FY2024, ended Dec 31, 2024 | 392M |
| FY2025, ended Dec 31, 2025 | 388M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 388M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $730M | $14.0M | — |
| FY2017, ended Dec 31, 2017 | $850M | $11.0M | — |
| FY2018, ended Dec 31, 2018 | $1.27B | $11.0M | — |
| FY2019, ended Dec 31, 2019 | $1.03B | $9.00M | $55.0M |
| FY2020, ended Dec 31, 2020 | $1.61B | — | — |
| FY2021, ended Dec 31, 2021 | $122M | — | — |
| FY2022, ended Dec 31, 2022 | $286M | — | — |
| FY2023, ended Dec 31, 2023 | $0 | — | — |
| FY2024, ended Dec 31, 2024 | $2.49B | — | — |
| FY2025, ended Dec 31, 2025 | $1.86B | — | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $555M | — | — |
Valuation
At current price- Market Cap
- $149B
- P/E
- 39.0×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 5.0×
- Price / Book
- 7.4×
- EV / EBITDA
- 26.3×
Growth
Trailing 12 months- Revenue (TTM)
- $30.0B
- Revenue Growth YoY
- 15.5%
- Revenue CAGR 3Y
- 9.8%
- Revenue CAGR 5Y
- 9.0%
- EPS Growth YoY
- −1.2%
- Net Income Growth YoY
- −2.4%
Profitability
Trailing 12 months- Gross Margin
- 35.9%
- Operating Margin
- —
- Net Margin
- 12.8%
- FCF Margin
- 13.1%
- Return on Equity
- 19.7%
Earnings
Trailing 12 months- Net Income
- $3.83B
- EPS (diluted)
- $9.82
- EBITDA
- $6.45B
- Operating Income
- —
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $483M
- Total Debt
- $20.6B
- Net Debt
- $20.1B
- Total Assets
- $56.2B
- Total Liabilities
- $35.9B
- Shareholders' Equity
- $20.3B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $4.95B
- Capital Expenditure
- $1.02B
- Free Cash Flow
- $3.93B
Dividends and risk
Last 12 months- Dividend Yield
- 1.1%
- Dividend / Share
- $4.34
- Beta (5Y)
- 1.13
Every ratio is calculated from the company’s reported figures.